Guide
Missing a GLP-1 Dose: What the Label Says and What to Ask
Both tirzepatide and semaglutide labels contain specific guidance on missed doses, and it differs between them. The general shape is that a dose can be taken within a def
Both tirzepatide and semaglutide labels contain specific guidance on missed doses, and it differs between them. The general shape is that a dose can be taken within a defined window, and outside that window you skip it and resume the schedule — but the windows are not the same drug to drug, and this is a question for your prescriber rather than a website.
Why we are cautious on this page
Missed-dose handling is one of the few areas where a website giving a confident number could cause real harm. The windows differ between drugs, they interact with where you are in titration, and a person who doubles up because a page told them the wrong thing has a bad week at best.
So this page tells you what kind of guidance exists, where it lives, and what to ask. It does not tell you what to do with your dose.
What the labels contain
Both the tirzepatide and semaglutide prescribing information include missed-dose sections. The structure is broadly similar and the specifics are not.
Each defines a window — measured in days from the scheduled dose — within which a missed dose may be taken. Outside that window, the direction is generally to skip the missed dose and take the next one at the usual time. Neither label directs doubling up.
The labels also address changing your dosing day, which has its own minimum-interval condition. That is the part people most often get wrong, because moving injection day feels administrative rather than clinical.
The three things that change the answer
Which drug. The windows are not identical between tirzepatide and semaglutide, and assuming they are is the most common error.
Where you are in titration. Missing a dose during escalation is a different situation from missing one at a steady maintenance dose, and it can affect whether your prescriber wants you to hold rather than advance at the next step.
How many you have missed. One missed dose and several missed weeks are different clinical situations. Restarting after an extended gap may involve going back down the titration ladder, because gastrointestinal tolerability is re-established rather than retained.
What to do
- Check your own prescribing information — the leaflet dispensed with your medication, or the label for your specific product.
- Contact your prescriber or pharmacist. This is a routine question and they will answer it quickly.
- Do not double up to compensate. No label directs this, and gastrointestinal adverse effects in this class are dose-related.
- Note it, so your prescriber knows at your next appointment. A missed dose can explain a change in appetite or weight trajectory that would otherwise look like something else.
Compounded products complicate this
A compounded preparation does not come with the manufacturer's prescribing information, and concentrations vary between compounders. If your medication is compounded, the missed-dose question goes to your prescriber rather than to a label you can look up — there may not be one for your specific preparation.
That is worth knowing before you need the answer at 10pm on a Sunday.
If missed doses are becoming a pattern
That is itself worth raising. Weekly dosing is easy to lose track of, and there are ordinary solutions — a fixed day, a reminder, aligning it with something you already do weekly. It may also be worth discussing whether the schedule suits your life, because adherence is what determines whether trial results have any bearing on your outcome.
| Step | What the label says | Status |
|---|---|---|
| Starting dosage | 2.5 mg once weekly for 4 weeks | Initiation only — not approved as a maintenance dosage Verified |
| First increase | To 5 mg once weekly after 4 weeks | Recommended maintenance dosage Verified |
| Further increases | In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response | A minimum interval, not a fixed calendar Verified |
| 7.5 mg and 12.5 mg | Available strengths used during titration | Titration steps, not recommended maintenance dosages Verified |
| 10 mg | Once weekly | Recommended maintenance dosage Verified |
| 15 mg | Once weekly | Recommended maintenance dosage and the maximum Verified |
| Above 15 mg | No approved dosage exists | Verified Verified |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
Questions readers actually ask
What happens if I miss a GLP-1 dose?
Both labels define a window within which a missed dose may be taken, and direct skipping it outside that window. The windows differ between drugs, so check your own prescribing information and ask your prescriber.
Can I take two doses to catch up?
No label directs doubling up, and gastrointestinal adverse effects in this class are dose-related. Ask your prescriber.
What if I have missed several weeks?
That is a different situation from one missed dose and may involve restarting at a lower dose, because tolerability is re-established rather than retained. It is a clinical decision.
Does this differ for compounded products?
Yes. A compounded preparation does not carry the manufacturer's prescribing information and concentrations vary between compounders, so the question goes to your prescriber.
Related on this site
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Ro Body vs Hims & HersComparisons
- Why Multi-Dose Vials Create Tirzepatide Dosing ErrorsJournal
- Microdose Tirzepatide: The Evidence GapJournal
- Brand-Name vs Compounded TirzepatidePillar / Money
- Zepbound vs MounjaroComparisons
- Tirzepatide for Type 2 DiabetesResearch
- Tirzepatide and Sleep Apnea: Evidence and FDA StatusJournal
Related coverage
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- Ro Body vs Mochi Health
- 503A vs 503B: A Patient Verification Checklist
- FDA Sends 25 More Warning Letters Over Compounded GLP-1 Marketing Claims
- Privacy Policy
- Tirzepatide Telehealth in Delaware
- Storing and Travelling With a GLP-1: Cold Chain, Airports and What Breaks
- bmiMD vs LillyDirect
GLP-1 Tirzepatide Reviews. “Missing a GLP-1 Dose: What the Label Says and What to Ask.” S.J Partners LLC, 2026-07-24. https://glptirzepatidereviews.com/missed-dose/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.